Pancreatic Cancer Research

Journal articlePharmacoepidemiol Drug Saf2018

Use of proton pump inhibitors and risk of pancreatic cancer.

Journal
Pharmacoepidemiol Drug Saf
Published
20 June 2018
Citations
17
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Purpose Preclinical studies have suggested that proton pump inhibitors (PPIs) may increase pancreatic cancer risk; however, epidemiological studies are few, with conflicting results. This spurred us to evaluate whether PPI use is associated with an increased risk of pancreatic cancer in a large population-based study. … Excerpt only: this text is the publisher’s. Read it in full at the source.